Cargando…
Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853271/ https://www.ncbi.nlm.nih.gov/pubmed/32801224 http://dx.doi.org/10.4103/ijmr.IJMR_2609_20 |
| _version_ | 1783645926552764416 |
|---|---|
| author | Neves, Fabricio Souza |
| author_facet | Neves, Fabricio Souza |
| author_sort | Neves, Fabricio Souza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7853271 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78532712021-02-04 Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 Neves, Fabricio Souza Indian J Med Res Correspondence Wolters Kluwer - Medknow 2020 /pmc/articles/PMC7853271/ /pubmed/32801224 http://dx.doi.org/10.4103/ijmr.IJMR_2609_20 Text en Copyright: © 2020 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Correspondence Neves, Fabricio Souza Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 |
| title | Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 |
| title_full | Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 |
| title_fullStr | Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 |
| title_full_unstemmed | Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 |
| title_short | Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2 |
| title_sort | optimal dosing & time: issues to get hydroxychloroquine safety & efficacy against covid-19/sars-cov-2 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853271/ https://www.ncbi.nlm.nih.gov/pubmed/32801224 http://dx.doi.org/10.4103/ijmr.IJMR_2609_20 |
| work_keys_str_mv | AT nevesfabriciosouza optimaldosingtimeissuestogethydroxychloroquinesafetyefficacyagainstcovid19sarscov2 |